Paris, FRANCE, April 24 (Korea Bizwire) - Rapid and decisive response to COVID-19 global health crisis Sanofi showed resilience and maintained full business continuity worldwide including its global industrial network. Separate collaborations announced with BARDA, Translate Bio and GSK to develop novel COVID-19 vaccines. Global clinical program underway to evaluate Kevzara® in patients hospitalized with severe [...]
Paris, FRANCE, Feb. 6 (Korea Bizwire) - Q4 2019 Change Change at CER 2019 Change Change at CER IFRS net sales reported €9,608m +6.8% +4.7% €36,126m +4.8% +2.8% IFRS net income reported -€10m -103.9%(2) - €2,806m -34.8%(2) - IFRS EPS reported -€0.01 -105.0%(2) - €2.24 -35.1%(2) - Business net income(1) €1,684m +23.5% +18.4% €7,489m [...]
Paris, Oct. 31 (Korea Bizwire) – Q3 2019 Change Change at CER 9M 2019 Change Change at CER IFRS net sales reported €9,499m +1.1% -1.1% €26,518m +4.1% +2.2% IFRS net income reported €1,766m -22.3% - €2,816m -30.5%(2) - IFRS EPS reported €1.49 -18.6% - €2.33 -28.3%(2) - Business net income(1) €2,399m +4.3% +0.2% €5,805m +6.4% [...]
Paris, Jul. 29 (Korea Bizwire) – Sanofi delivered solid growth in Q2 2019 Q2 2019 Change Change at CER H1 2019 Change Change at CER IFRS net sales reported €8,628m +5.5% +3.9% €17,019m +5.9% +4.1% IFRS net income reported -€87m -111.4%(2) - €1,050m -40.9% - IFRS EPS reported -€0.07 -111.5%(2) - €0.84 -40.8% - [...]
SEOUL, Nov. 24 (Korea Bizwire) – Hanmi Pharmaceutical Co. is heading toward its best year ever with six licensing deals and collaboration projects worth a combined 7.6 trillion won (US$6.55 billion). The South Korean company has bagged a series of deals on licensing of its pipeline products and collaborative research and development of early treatment [...]